{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:37:35Z","timestamp":1786995455368,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.oret.2022.04.012","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T17:40:03Z","timestamp":1650476403000},"page":"914-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Differences in Long-Term Progression of Atrophy between Neovascular and Nonneovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"6","author":[{"given":"Matteo","family":"Airaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Corvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeswar Gupta","family":"Nittala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Staurenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SriniVas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2022.04.012_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2022.04.012_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000363187","article-title":"Treatment of dry age-related macular degeneration","volume":"52","author":"Querques","year":"2014","journal-title":"Ophthal Res"},{"key":"10.1016\/j.oret.2022.04.012_bib4","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2022.04.012_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/bjo.60.5.324","article-title":"Ageing and degeneration in the macular region: a clinico-pathological study","volume":"60","author":"Sarks","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib6","first-page":"180","article-title":"Key 3rd SN. Senile macular degeneration: a histopathologic study","volume":"75","author":"Green","year":"1977","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2022.04.012_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00417-020-04821-6","article-title":"Optical coherence tomography angiography for detection of macular neovascularization associated with atrophy in age-related macular degeneration","volume":"259","author":"Corvi","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ophtha.2017.12.026","article-title":"Macular atrophy in the HARBOR study for neovascular age-related macular degeneration","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ophtha.2016.10.002","article-title":"Macular atrophy in neovascular age-related macular degeneration with monthly versus treat-and-extend ranibizumab: findings from the TREX-AMD trial","volume":"124","author":"Abdelfattah","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ophtha.2019.09.030","article-title":"Spectral-domain OCT-based prevalence and progression of macular atrophy in the HARBOR study for neovascular age-related macular degeneration","volume":"127","author":"Gune","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib11","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ophtha.2020.03.031","article-title":"Spectral-domain OCT analysis of risk factors for macular atrophy development in the HARBOR study for neovascular age-related macular degeneration","volume":"127","author":"Sadda","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212563","article-title":"Choriocapillaris flow impairment surrounding geographic atrophy correlates with disease progression","volume":"14","author":"Nassisi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2022.04.012_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00417-020-04615-w","article-title":"Relationship between proximity of choriocapillaris flow deficits and enlargement rate of geographic atrophy","volume":"258","author":"Alagorie","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/IAE.0000000000002906","article-title":"Topographic assessment of choriocapillaris flow deficits in the intermediate age-related macular degeneration eyes with hyporeflective cores inside drusen","volume":"41","author":"Byon","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.04.012_bib15","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s00417-021-05167-3","article-title":"Topography of choriocapillaris flow deficit predicts development of neovascularization or atrophy in age-related macular degeneration","volume":"259","author":"Corvi","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0000000000002990","article-title":"Choriocapillaris flow deficits as a risk factor for progression of age-related macular degeneration","volume":"41","author":"Corvi","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.04.012_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2006.11.041","article-title":"Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration","volume":"143","author":"Holz","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.oret.2019.09.016","article-title":"Type 1 choroidal neovascularization is associated with reduced localized progression of atrophy in age-related macular degeneration","volume":"4","author":"Pfau","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2022.04.012_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ophtha.2020.01.040","article-title":"Nonexudative macular neovascularization supporting outer retina in age-related macular degeneration: a clinicopathologic correlation","volume":"127","author":"Chen","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.9.8.8","article-title":"Recognizing atrophy and mixed-type neovascularization in age-related macular degeneration via clinicopathologic correlation","volume":"9","author":"Chen","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.oret.2022.04.012_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcjo.2021.01.005","article-title":"Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration","volume":"56","author":"Corradetti","year":"2021","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib24","series-title":"Fundamentals of Biostatistics","first-page":"301","article-title":"Estimation of sample size and power for comparing two means","author":"Rosner","year":"2016"},{"key":"10.1016\/j.oret.2022.04.012_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamaophthalmol.2013.572","article-title":"Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26","volume":"131","author":"Feuer","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1167\/tvst.7.6.40","article-title":"The rate of progression of geographic atrophy decreases with increasing baseline lesion size even after the square root transformation","volume":"7","author":"Mon\u00e9s","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.oret.2022.04.012_bib27","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ophtha.2019.12.009","article-title":"Natural history of geographic atrophy secondary to age-related macular degeneration: results from the prospective Proxima A and B clinical trials","volume":"127","author":"Holekamp","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib28","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.ophtha.2016.06.025","article-title":"Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: Age-Related Eye Disease Study 2 report number 11","volume":"123","author":"Domalpally","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.oret.2022.04.012_bib30","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.oret.2018.04.009","article-title":"Atrophy in neovascular age-related macular degeneration: Age-Related Eye Disease Study 2 report number 15","volume":"2","author":"Domalpally","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2022.04.012_bib31","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.ophtha.2020.06.019","article-title":"Macular atrophy incidence and progression in eyes with neovascular age-related macular degeneration treated with vascular endothelial growth factor inhibitors using a treat-and-extend or a pro re nata regimen: four-year results of the MANEX study","volume":"127","author":"Spooner","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib32","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ajo.2015.01.032","article-title":"Macular atrophy progression and 7-year vision outcomes in subjects from the Anchor, Marina, and HORIZON studies: the SEVEN-UP study","volume":"159","author":"Bhisitkul","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ophtha.2016.09.012","article-title":"Incidence and growth of geographic atrophy during 5 years of comparison of age-related macular degeneration treatments trials","volume":"124","author":"Grunwald","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.04.012_bib34","doi-asserted-by":"crossref","first-page":"100906","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2022.04.012_bib35","first-page":"189","article-title":"Regulation of signaling events involved in the pathophysiology of neovascular AMD","volume":"22","author":"Wang","year":"2016","journal-title":"Mol Vis"},{"key":"10.1016\/j.oret.2022.04.012_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ajo.2014.07.006","article-title":"The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration","volume":"158","author":"Jung","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.04.012_bib37","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1167\/iovs.18-25702","article-title":"Three-dimensional adaptive optics-assisted visualization of photoreceptors in healthy and pathologically aged eyes","volume":"60","author":"Reumueller","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2022.04.012_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-030-66014-7_2","article-title":"Ocular imaging for enhancing the understanding, assessment, and management of age-related macular degeneration","volume":"1256","author":"Nassisi","year":"2021","journal-title":"Adv Exp Med Biol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022001890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022001890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:30:42Z","timestamp":1762853442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653022001890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2468653022001890"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2022.04.012","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Long-Term Progression of Atrophy between Neovascular and Nonneovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2022.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}